Amalgamated Bank’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Amalgamated Bank’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-5,378	Closed	-$250K	–	3044
2023 Q2	$250K	Buy	5,378 +1,652	+44%	+$57.1K	﹤0.01%	1734
2023 Q1	$107K	Sell	3,726 -927	-20%	-$27.5K	﹤0.01%	2030
2022 Q4	$145K	Buy	4,653 +1,057	+29%	+$34.5K	﹤0.01%	1980
2022 Q3	$73K	Hold	3,596	–	–	﹤0.01%	2296
2022 Q2	$56K	Buy	3,596 +1,567	+77%	+$27K	﹤0.01%	2417
2022 Q1	$39K	Buy	+2,029	New	+$36.2K	﹤0.01%	2588

Amalgamated Bank's DICE Position: Q3 2023 in Review

Amalgamated Bank sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 5,378 shares — an estimated $250K sold.

Amalgamated Bank first reported a position in DICE in Q1 2022 and held it in 6 quarters. The position peaked at $250K in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

Amalgamated Bank reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Amalgamated Bank sold 5,378 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $250K.
Amalgamated Bank first reported a position in DICE Therapeutics, Inc. Common Stock in Q1 2022 and held it in 6 quarters.
Amalgamated Bank's DICE Therapeutics, Inc. Common Stock position peaked at $250K in Q2 2023.
0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Amalgamated Bank's 13F filing for Q3 2023, filed 8 Nov 2023.